Novavax Ownership | Who Owns Novavax?

Overview Forecast RevenueFinancials Chart Transcripts

Novavax Ownership Summary

Novavax is owned by 72.59% institutional investors, 5.06% insiders, and 22.35% retail investors. Vanguard group is the largest institutional shareholder, holding 9.53% of NVAX shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.50% of its assets in Novavax shares.

NVAX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Novavax	72.59%	5.06%	22.35%
Sector	Healthcare Stocks	50.47%	12.28%	37.25%
Industry	Biotech Stocks	49.08%	12.05%	38.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	15.47M	9.53%	$103.96M
Shah capital management	14.17M	8.68%	$133.44M
Blackrock funding, inc. /de	13.95M	8.54%	$131.38M
Blackrock	11.85M	8.47%	$149.98M
State street	11.74M	7.19%	$110.60M
Vanguard capital management	7.26M	4.44%	$68.37M
Sanofi	6.88M	4.21%	$64.81M
D. e. shaw	5.65M	3.46%	$53.23M
Geode capital management	4.21M	2.58%	$39.64M
Two sigma investments, lp	4.09M	2.51%	$38.54M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Shah capital management	14.17M	25.36%	$133.44M
Sanofi	6.88M	12.14%	$64.81M
Tsp capital management group	1.42M	3.20%	$13.37M
Monaco asset management sam	577.46K	0.43%	$5.44M
Crawford fund management	101.00K	0.32%	$1.28M
Virtus investment advisers	130.96K	0.29%	$1.23M
Headlands	190.55K	0.19%	$1.79M
Palumbo wealth management	92.95K	0.18%	$875.56K
Edgestream partners	559.80K	0.16%	$5.27M
Skaana management	68.30K	0.15%	$458.98K

Top Buyers

Holder	Shares	% Assets	Change
Two sigma investments, lp	4.09M	0.03%	3.48M
State street	11.74M	0.00%	2.77M
Blackrock	11.85M	0.00%	2.42M
Goldman sachs group	3.01M	0.00%	1.60M
Sixth street partners management company	1.35M	0.00%	1.35M

Top Sellers

Holder	Shares	% Assets	Change
Bank of america corp /de/	3.42M	0.00%	-3.22M
Ubs group	1.87M	0.00%	-2.61M
Park west asset management	-	-	-2.53M
Millennium management	1.77M	0.01%	-2.08M
D. e. shaw	5.65M	0.03%	-2.06M

New Positions

Holder	Shares	% Assets	Change	Value
Sixth street partners management company	1.35M	0.00%	1.35M	$12.69M
Jefferies financial group	673.12K	0.04%	673.12K	$5.48M
Trexquant investment lp	461.74K	0.03%	461.74K	$4.35M
Algert global	277.99K	0.03%	277.99K	$2.62M
Nebula research & development	146.53K	0.08%	146.53K	$923.13K

Sold Out

Holder	Change
Global financial private client	-1.00
Wolff wiese magana	-1.00
Golden state wealth management	-2.00
Strategic advocates	-2.00
Raleigh capital management	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	295	3.51%	118,518,738	0.45%	72	1.37%	121	-3.20%	84	7.69%
Mar 31, 2026	276	2.99%	110,646,803	-6.08%	68	1.30%	118	22.92%	78	-11.36%
Dec 31, 2025	122	-57.19%	57,021,867	-44.74%	35	0.87%	44	-65.35%	37	-47.14%
Sep 30, 2025	98	-66.44%	29,983,130	-70.63%	18	0.47%	43	-68.38%	26	-51.85%
Jun 30, 2025	290	4.32%	102,039,260	3.62%	62	1.68%	135	14.41%	55	-25.68%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	7.39M	4.50%	16.97K
Vanguard Morn Total Stk Mkt Idx Investor	5.20M	3.16%	62.45K
Vanguard Total Stock Mkt Idx Inv	5.20M	3.16%	62.45K
Vanguard US Total Market Shares ETF	4.86M	3.02%	603.27K
iShares Russell 2000 ETF	3.86M	2.35%	-68.64K
Vanguard Small Cap Index	3.78M	2.30%	19.02K
SPDR® S&P Biotech ETF	3.09M	1.91%	6.91K
Vanguard Morn Small Cap Growth Index Inv	2.19M	1.33%	82.45K
Vanguard Small Cap Growth Index Inv	2.19M	1.33%	82.45K
Vanguard Institutional Extnd Mkt Idx Tr	1.89M	1.15%	52.78K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 13, 2024	King Rachel K.	-	Sell	$37.44K
Dec 31, 2024	YOUNG JAMES F	-	Sell	$43.20K
Dec 24, 2024	YOUNG JAMES F	-	Sell	$39.01K
Jun 21, 2024	YOUNG JAMES F	-	Sell	$105.67K
Jun 18, 2024	YOUNG JAMES F	-	Sell	$15.81K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-

NVAX Ownership FAQ

Who Owns Novavax?

Novavax shareholders are primarily institutional investors at 72.59%, followed by 5.06% insiders and 22.35% retail investors. The average institutional ownership in Novavax's industry, Biotech Stocks , is 49.08%, which Novavax exceeds.

Who owns the most shares of Novavax?

Novavax’s largest shareholders are Vanguard group (15.47M shares, 9.53%), Shah capital management (14.17M shares, 8.68%), and Blackrock funding, inc. /de (13.95M shares, 8.54%). Together, they hold 26.75% of Novavax’s total shares outstanding.

Does Blackrock own Novavax?

Yes, BlackRock owns 8.47% of Novavax, totaling 11.85M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 149.98M$. In the last quarter, BlackRock increased its holdings by 2.42M shares, a 25.65% change.

Who is Novavax’s biggest shareholder by percentage of total assets invested?

Shah capital management is Novavax’s biggest shareholder by percentage of total assets invested, with 25.36% of its assets in 14.17M Novavax shares, valued at 133.44M$.

Who is the top mutual fund holder of Novavax shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Novavax shares, with 4.50% of its total shares outstanding invested in 7.39M Novavax shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools